EFFECTIVE DATE: October 26, 2010

Terms of Service

Calmare Therapeutics Incorporated (CTI) maintains the Web Site calmaretherapeutics.com (the "Site") for your information, education, communication and personal enjoyment. Access to and use of this Site are subject to the terms and conditions set forth below:

  1. CTI makes no representations or warranties as to the accuracy, reliability or completeness of the information, text, graphics, links, content or other items contained in the Site or in any site linked to or from the Site. CTI expressly disclaims liability for any errors or omissions in the materials contained in the Site or in any site linked to or from the Site. CTI reserves the right to make changes in the programs, policies, products and services described in this Site at any time without notice.
  2. The information and materials contained in this Site are provided to you "As Is" and your use of this Site or any site linked to or from this Site is solely at your own risk. CTI MAKES NO WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT. CTI shall have no responsibilities to update any content or information contained on the Site. CTI expressly disclaims any liability, contingent or otherwise, for any damage to or viruses that may infect your computer or other property due to your use of this Site or any site linked to or from this Site or your downloading of any materials, text or images from the Site or from any site linked to or from the Site. CTI SHALL NOT BE LIABILE FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, SPECIAL, INCIDENTAL OR PUNITIVE DAMAGES ARISING OUT OF YOUR ACCESS TO OR USE OF THIS SITE OR ANY SITE LINKED TO OR FROM THIS SITE.
  3. For our customers' convenience, CTI provides links to other sites. In addition, links to this Site may be provided from other sites either known or unknown to CTI. CTI is not responsible for the content of any site that is linked to or from this Site. The fact that another site is linked to or from this Site does not imply that: (a) CTI sponsors, licenses, authorizes, endorses, is affiliated with, or is otherwise connected to such site, the products or services described therein or its owners or providers; or (b) CTI has authorized the linked site to use any trademark, trade name, logo or other trademarked or copyrighted material of CTI.
  4. The trademarks, service marks, trade names, logos and other indications of origin displayed in this Site ("Trademarks") are owned by CTI or a third party who has granted CTI a right to use them in this Site. Such third parties shall have no liability to you for monetary damages on account of any Trademarks displayed herein. Nothing contained herein should be construed as granting the browser or user of this Site the right to use any Trademark displayed in this Site without the written permission of the owner of the Trademark. These Web Site Terms of Service are not intended to, and will not, transfer or grant any rights in or to the contents of the Site other than those which are specifically described herein.
  5. Any materials, communications or information sent to this Site (Information) will be deemed NOT CONFIDENTIAL and NONPROPRIETARY and will become the property of CTI. CTI may use such Information for any purpose whatsoever, including but not limited to the use of any ideas, concepts, know-how or techniques contained in the Information. CTI may reproduce, display, transmit, perform, publish and broadcast the Information at any time and in any media.
  6. CTI reserves the right, at anytime and from time to time, in its own business judgment, to add, remove, revise or modify any of the contents of the Site, including these Web Site Terms of Service. You agree that your continued access and use of this Site shall bind you to any new terms or conditions that may be posted on this Site from time to time and that you are required to read the same.
  7. Neither CTI nor any third party shall have any responsibility to maintain the information or content made available on the Site or to supply any corrections, updates or releases in connection therewith. Availability of information and content are subject to change without notice.
Copyright & Permissions

Materials available on the Site are protected by the copyright laws of the United States and other countries. Copyright Calmare Therapeutics Incorporated © 1999-2024. All rights reserved.

When you access the Site, you agree to the following Terms of Use:

  • You may retrieve the contents of the Site for informational purposes only.
  • You may save a local copy or send it to your printer for your own personal use. However, you may not charge any fees or other form of compensation or remuneration for such use.
  • You are not permitted to publish, transmit or otherwise reproduce the contents of the Site, in whole or in part, in any format to any third party without the express written consent of CTI.
  • You must include the copyright notice in any copy that you make and you are not permitted to alter, obscure, or remove any such copyright, any trademark or any other notices that are provided to you in connection with the contents of the Site.
  • You may not modify the information found in the Site without the express permission of CTI.
Linking to this Site

All links to this Site must be approved in writing by CTI, except that CTI consents to links in which the link and the pages that are activated by the link do not: (a) create frames around any page on this Site or use other techniques that alter in any way the visual presentation or appearance of any content within this Site; (b) misrepresent your relationship with CTI; (c) imply that CTI approves or endorses you, your web site, or your service or product offerings; and (d) present false or misleading impressions about CTI or otherwise damage the goodwill associated with the CTI name or trademarks. As a further condition to being permitted to link to this Site, you agree that CTI may at any time, in its sole discretion, terminate permission to link to this Site. In such event, you agree to immediately remove all links to this Site and to cease using any CTI trademark.

EFFECTIVE DATE: October 26, 2010

CTI Online Privacy Statement

Calmare Therapeutics Incorporated and its subsidiaries and affiliates (collectively, "CTI") respect your privacy and are committed to protecting it. Please read this CTI Online Privacy Statement (the "Privacy Policy") to be informed of our Privacy Policy and practices and about the way your information is collected online. The Privacy Policy applies to personal and technology information collected by CTI through its web site calmaretherapeutics.com (the "Site"). Personal Information means any information that may be used to identify an individual, including, but not limited to, a first and last name, a home or other physical address and an email address or other contact information, whether at work or at home. In general, you can visit the Site without telling us who you are or revealing any Personal Information about yourself. Technology Information means any information you submit to CTI for evaluation or review or for any other purpose through the Site which relates to technologies, intellectual property or the like. You can also visit the Site without submitting or revealing any Technology Information. CTI strives to comply with all applicable laws that are designed to protect your privacy.


The Site may provide links to third-party web sites for your convenience and information. If you access those links, you will leave the Site. CTI does not control these web sites or their privacy practices, which may differ from the Site's. We do not endorse or make any representations about third-party web sites. The Personal Information or Technology Information you choose to give to unrelated third parties is not covered by our Privacy Policy. We encourage you to review the privacy policy of any company before submitting your Personal Information or Technology Information.


CTI is committed to protecting the privacy needs of children. CTI does not knowingly collect information from children under the age of 13, and no part of the Site is structured to attract any person under the age of 13.


CTI uses your Personal Information and/or Technology Information (collectively, Information) to provide you with services and to help us better understand your needs and interests. Specifically, we use your Information to communicate with you and to provide service and support. If you choose to have a relationship with CTI, such as a contractual or other business relationship or partnership, we will naturally continue to contact you in connection with that business relationship.


CTI will not sell, rent or lease your Personal Information to others. CTI will not share your Information with any third parties without your permission, unless to: (i) respond to duly authorized information requests of government authorities, (ii) comply with any law, regulation, subpoena, or court order, (iii) help prevent fraud or to enforce or protect the rights and properties of CTI, or (iv) to protect the personal safety of CTI employees and third parties on CTI property.


CTI is committed to protecting the Information you provide us. To prevent unauthorized access or disclosure, to maintain data accuracy, and to ensure the appropriate use of the Information, CTI has in place appropriate physical, electronic and managerial procedures to safeguard and secure the Information we collect online.


By using the Site, you consent to the terms of our Privacy Policy and to CTI's processing of Personal Information and Technology Information. Should the Privacy Policy change, we intend to take every reasonable step to ensure that these changes are brought to your attention by posting all changes prominently on our website for a reasonable period of time.


This Privacy Policy is effective as of October 26, 2010.


CTI welcomes your comments regarding this Privacy Policy. If you have questions about the Privacy Policy or believe that we have not adhered to it, please contact us by emailing your comments to This email address is protected. Javascript must be enabled to view it. or by mailing your comments to us at: CTI Privacy Policy, Calmare Therapeutics Incorporated, 2 Trap Falls Rd. STE 507, Shelton, CT 06484.

EFFECTIVE DATE: April 30, 2007

RSS Terms of Service

These RSS Terms of Service, CTI's Privacy Policy, and our general Terms of Service govern your use of RSS content provided by CTI. Any uses of RSS content not granted herein are strictly prohibited. Prohibited uses include, but are not limited to, the incorporation of advertising or the placement of advertising associated with or targeted at the RSS content. You may not edit or modify the RSS feeds in any manner whatsoever. RSS feeds may be used only with platforms with a functional link which takes the viewer directly to the full article on the Site. You may not insert any intermediate page, splash page or any other content between the RSS link and the applicable article on the Site. CTI retains all ownership and other rights in the RSS content and in any and all CTI logos and trademarks used in connection with RSS feeds. If you provide attribution using a graphic, you must use the appropriate CTI logo incorporated into the RSS content or feed.

CTI reserves the right to cease offering any or all of the RSS feeds at any time or to require you to cease distributing any or all of the feeds at any time for any reason. CTI assumes no liability for your activities in connection with the RSS feeds or for your use of the feeds in connection with your web site.

EFFECTIVE DATE: April 9, 2007

Digital Millennium Copyright Act Notices

It is the policy of Calmare Therapeutics Incorporated ("CTI") to respect the intellectual property of others and thus to respond to effective notices of alleged infringement of copyrighted material where (i) the copyrighted material is available at, or from, a system or network controlled or operated by or for CTI or where (ii) CTI, by providing or using an information location tool, such as a directory, index, reference, pointer, or hypertext link, refers or links a third party to a site that contains the copyrighted material.

If you are alleging that copyrighted material may have been or is being infringed, then you may notify CTI, pursuant to the U.S. Online Copyright Infringement Liability Limitation Act of the U.S. Digital Millennium Copyright Act, 17 U.S.C. §512 (c), by sending a notice to the address listed below. Such notice must include the following to be effective:

  1. A physical or electronic signature of a person authorized to act on behalf of the owner of an exclusive right that is allegedly infringed;
  2. Identification of the copyrighted work claimed to have been infringed or, if multiple copyrighted works at a single online site are covered by a single notification, a representative list of such works at that site;
  3. Identification of the material that is claimed to be infringing or to be the subject of infringing activity and that is to be removed or access to which is to be disabled, and information reasonably sufficient to permit CTI to locate the material;
  4. Information reasonably sufficient to permit CTI to contact you such as an address, telephone number, and, if available, an electronic mail address at which you may be contacted;
  5. A statement that you have a good faith belief that use of the material in the manner complained of is not authorized by the copyright owner, its agent, or the law; and
  6. A statement that the information in the notification is accurate and, under penalty of perjury, that you are authorized to act on behalf of the owner of an exclusive right that is allegedly infringed.
Counter Notices

If material that you have posted to a system or network controlled or operated by or for CTI has been removed or disabled, you may file a counter notice pursuant to 17 U.S.C. §512 (g). To be effective, the counter notice must be a written communication sent to the address listed below that includes the following:

  1. A physical or electronic signature of the subscriber;
  2. Identification of the material that has been removed or to which access has been disabled and the location at which the material appeared before it was removed or access to it was disabled;
  3. A statement under penalty of perjury that you have a good faith belief that the material was removed or disabled as a result of mistake or misidentification of the material to be removed or disabled; and
  4. Your name, address, and telephone number, and a statement that you consent to the jurisdiction of Federal District Court for the judicial district in which the address is located or, if your address is outside of the United States, for any judicial district in which CTI may be found, and that you will accept service of process from the person who provided notification under subsection 17 U.S.C. §512 (c)(1)(C) or an agent of such person.
Designated Agent for all Notices, Including Counter Notices

All written notices should be sent to the following Designated Agent:

General Counsel
Calmare Therapeutics Incorporated
2 Trap Falls Rd. STE 507
Shelton, CT 06484